I agree that MSB should unambiguously state if Teva saw the yes/no from the surrogate endpoint analysis, and they should release it to the ASX, not via an email.
I haven't seen any FDA ruling that this data couldn't be released to Teva, especially since it has been part of the trial design from the beginning. Can you find a source?
- Forums
- ASX - By Stock
- MSB
- CHF trial mythbusting
MSB
mesoblast limited
Add to My Watchlist
8.70%
!
$1.68

CHF trial mythbusting, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.68 |
Change
-0.160(8.70%) |
Mkt cap ! $2.143B |
Open | High | Low | Value | Volume |
$1.81 | $1.83 | $1.68 | $11.30M | 6.548M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 82773 | $1.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 19054 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 82189 | 1.675 |
17 | 49803 | 1.670 |
15 | 100519 | 1.665 |
13 | 163722 | 1.660 |
7 | 66587 | 1.655 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 40510 | 52 |
1.685 | 37369 | 48 |
1.690 | 42376 | 9 |
1.695 | 113094 | 10 |
1.700 | 87214 | 7 |
Last trade - 14.48pm 02/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online